Malaria :: Asia-Pacific region at an increased risk of malaria, says WHO
A World Health Organization official has issued a warning about the increased risk of malaria to countries in the Asia-Pacific region, the Bangkok Post reports.
Malaria
HIV :: First-year success reported for UN-backed HIV and TB drug facility for poor
In the year since it was established to provide medicines for HIV/AIDS, malaria and tuberculosis to the poorest people of developing countries, the United Nations-backed international drug purchase facility UNITAID has managed to reduce the price of HIV treatments for children by almost 40 per cent.
West Nile Virus :: UGA Odum School of Ecology professor receives grant to study West Nile Virus in NYC
When West Nile virus first struck New York City in 1999, news of the potentially fatal illness alarmed citizens and public health officials alike, showing that even affluent, urban societies are vulnerable to vector-borne diseases.
HIV :: UNITAID celebrates major achievements in first year of existence
In the year since it was established, the international drug purchase facility UNITAID has managed to reduce the price of HIV treatments for children by almost 40%, and those for second-line antiretroviral (ARV) drugs by between 25% and 50%.
Vaccine :: New nanoparticle vaccine is more effective but less expensive
Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.
Malaria :: GenVec to develop new malaria vaccine for US military
GenVec, Inc. (Nasdaq: GNVC) announced that it has entered into a collaborative research and development agreement (CRADA) with the U.S. Military Malaria Vaccine Program at the Walter Reed Army Institute of Research (WRAIR) and the Naval Medical Research Center (NMRC) for the development and pre-clinical testing of a malaria vaccine candidate against Plasmodium vivax (P. vivax).
Malaria :: Sugar identified as key to malaria parasite invasion
Researchers at the Johns Hopkins Malaria Research Institute (JHMRI) have identified a sugar in mosquitoes that allows the malaria-causing parasite, Plasmodium falciparum, to attach itself to the mosquito?s gut.
Malaria :: Heeding the WARNing from malaria’s past
A global network to monitor drug resistance and guide malaria treatment and prevention policies is being launched. As outlined in a series of articles in the online open access publication, Malaria Journal, the World Antimalarial Resistance Network (WARN) aims to provide a globally co-ordinated effort to tackle the disease, which is estimated to kill between 1 and 2.7 million people every year.
Cholera :: Climatic variations influence the emergence of cholera in Africa
In studies aiming to understand better the emergence and persistence of cholera in Africa, IRD and CNRS researchers showed the strong correlation that exists between outbreaks and the different parameters linked to climate changes in West Africa.
Malaria :: Binghamton University researchers investigate evolving malaria resistance
Funded by a $1.5 million grant from the National Institutes of Health, scientists at Binghamton University, State University of New York, hope to understand how the malaria parasite Plasmodium falciparum evolved resistance to the once-effective medication chloroquine.